Darwin Ventures
Taiwan-founded VC by two Stanford-trained semiconductor engineers, pivoting from chips to software/deep tech spinouts from academia since 2014.
DaVita Venture Group
Corporate venture arm of DaVita investing in kidney care innovation across digital health, care models, pharma, devices, and adjacent clinical services.
Daybreak Ventures
Early-stage VC writing first checks to founders reshaping markets or inventing new ones
DAYLI Partners
Seoul-based Korean VC specializing in bio-healthcare and fintech, managing 47 funds with ~₩685B cumulative AUM across 123 portfolio companies.
DC Global Ventures
Cross-border US-China life-sciences investor (formerly Decheng Capital), $2.5B AUM since 2012, backing biopharma and diagnostics early-to-growth.
DCM Ventures
Global early-stage VC founded in 1996, backing 400+ companies across consumer, fintech, enterprise SaaS, and AI with offices in the US, Japan, and China.
Decelera Ventures
Madrid-based founder-centric VC and decelerator program backing pre-seed and seed mission-driven tech startups across Southern Europe, with €38M under management.
Decheng Capital
Global life sciences VC with $2.5B+ AUM backing early-stage biotech and growth-stage healthcare companies across the US and China since 2012.
Deep Track Capital
Greenwich-based life sciences crossover fund investing in public equities and pre-IPO biotechnology companies, with $5B+ AUM and a fundamentally driven research approach.
DeepCore
SoftBank-owned Tokyo incubator and VC for AI/deep-tech founders, running the KERNEL community alongside University of Tokyo's Matsuo Lab.
DeepTech & Climate Fonds (DTCF)
A public venture fund investing in deep tech and climate tech companies across Germany.
DeepWork Capital
Orlando-based early-stage VC investing in tech and life sciences startups across underserved US regions, primarily Florida, at seed and Series A stages.
Deerfield Management
Investment firm dedicated to advancing healthcare through investment, intelligence, and philanthropy.
Define Ventures
Silicon Valley-based digital health VC with $800M AUM across 6 funds, backing early-stage health tech companies from incubation through Series B.
Defy.vc
San Francisco Bay Area early-stage VC backing authentic founders across consumer, enterprise, deep tech, and vertical SaaS, with a curated sage advisor network.
Deloitte Ventures
Deloitte Canada's $150M corporate VC arm, launched 2022, backs Series A/B B2B software in fintech, healthtech and cyber, both directly and as an LP.
Delos Capital
We empower life sciences leaders to turn bold ideas into medical breakthroughs
Delphinus Venture Capital
Danish evergreen VC investing pre-seed to Series B in deep tech across food, health, defence, and energy; EUR 80M fund, Aarhus-based.
Deming Center Venture Fund
Graduate-student-run fund giving CU Boulder MBA, law, and engineering students hands-on VC experience by investing real capital in Colorado startups.
Demos Capital
Early-stage VC combining capital with brand-building services
Denali Growth Partners
Boston growth-equity firm backing founder-led healthcare and tech companies, closing its second $400M fund on the strength of lowering care costs.
Designer Fund
San Francisco-based pre-seed to Series A fund backing design-led tech founders improving health, climate, and prosperity, with hands-on design support.
Deviation Capital
Early-stage firm backing technical founders at Seed and Series A in AI, robotics, biotech, and data infrastructure; spun out from Two Sigma as Deviation Capital in May 2026.
DFJ Growth
Growth-stage investor partnering with visionary founders
Showing 361–384 of 1406 investors
Get the Complete Healthcare Investor Database
1406 investors · Stages · Sectors · Locations · CSV + Excel
Get all 1406 investors →